Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
325.30
+8.21 (2.59%)
Nov 21, 2024, 1:53 PM EST - Market open
Madrigal Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -518.67 | -373.63 | -295.35 | -241.85 | -202.24 | -83.95 | |
| Depreciation & Amortization | 0.88 | 0.53 | 0.47 | 0.41 | 0.47 | 0.11 | |
| Other Amortization | 2.36 | 2.41 | 0.8 | - | - | - | |
| Stock-Based Compensation | 77.06 | 49.74 | 31.63 | 26.87 | 20.73 | 22.76 | |
| Other Operating Activities | -0.46 | - | - | - | - | - | |
| Change in Accounts Receivable | -30.46 | - | - | - | - | - | |
| Change in Accounts Payable | 29.42 | 4.21 | 2.45 | 20.36 | -0.16 | -1.31 | |
| Change in Other Net Operating Assets | 17.57 | -7.49 | 35.15 | 10.29 | 23.64 | 20.76 | |
| Operating Cash Flow | -431.02 | -324.23 | -224.86 | -183.92 | -157.56 | -41.62 | |
| Capital Expenditures | -2.3 | -1.48 | -0.22 | -0.21 | -0.33 | -0.17 | |
| Investment in Securities | -581.26 | -501.04 | 206.9 | -4.85 | 160.11 | 30.88 | |
| Investing Cash Flow | -588.56 | -502.52 | 206.69 | -5.06 | 159.78 | 30.71 | |
| Long-Term Debt Issued | - | 65 | 50 | - | - | - | |
| Total Debt Issued | - | 65 | 50 | - | - | - | |
| Net Debt Issued (Repaid) | - | 65 | 50 | - | - | - | |
| Issuance of Common Stock | 1,195 | 530.48 | 264.34 | 171.24 | 5.09 | 0.24 | |
| Other Financing Activities | - | -0.36 | -0.89 | - | - | - | |
| Financing Cash Flow | 1,195 | 595.12 | 313.45 | 171.24 | 5.09 | 0.24 | |
| Net Cash Flow | 175.63 | -231.63 | 295.28 | -17.74 | 7.31 | -10.68 | |
| Free Cash Flow | -433.32 | -325.71 | -225.07 | -184.13 | -157.9 | -41.8 | |
| Free Cash Flow Per Share | -20.90 | -17.43 | -13.13 | -11.14 | -10.22 | -2.71 | |
| Levered Free Cash Flow | -263.11 | -192.38 | -115.68 | -94.62 | -86.74 | -19.96 | |
| Unlevered Free Cash Flow | -256.01 | -186.85 | -114 | -94.62 | -86.74 | -19.96 | |
| Change in Net Working Capital | -15.9 | -2.17 | -37.61 | -29.87 | -21.56 | -16.7 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.